Shambo S. Samajdar, Department of Diabetes and Allergy-Asthma, Therapeutics Specialty Clinic, Kolkata, West Bengal, India.
Shashank R. Joshi, Department of Endocrinology, Joshi Clinic, Mumbai, Maharashtra, India.
Subhro Chakraborty, Department of Cardiology, R. G. Kar Medical College and Hospital, Kolkata, West Bengal, India.
Sougata Sarkar, Department of Clinical Pharmacology, School of Tropical Medicine, Kolkata, West Bengal, India.
Sunip Banerjee, Department of Cardiology, Kolkata Heart Lung Centre, Kolkata, West Bengal, India.
Anuj Maheshwari, Department of Medicine, Hind Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Ajoy Tewari, Department of Medicine, Hind Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
N. K. Singh, Department of Medicine, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India.
ABSTRACT
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally, placing a substantial burden on public health systems. Effective management of these chronic conditions requires long-term adherence to medication regimens aimed at controlling risk factors such as hypertension, diabetes, dyslipidemia, and obesity. Medication adherence, as defined by the World Health Organization (WHO), is the extent to which a person's behavior aligns with the agreed recommendations of a healthcare provider. Adherence is a critical determinant of therapeutic success, particularly in elderly populations who often face challenges due to multiple comorbidities, polypharmacy, cognitive decline, and socioeconomic factors. This review highlights the importance of medication adherence in managing CVDs, emphasizing its role in reducing adverse cardiovascular events, minimizing healthcare utilization, and preventing disease progression. We explore the multifaceted factors influencing adherence, including patient-related, medication-related, healthcare provider-related, healthcare system-related, and socioeconomic determinants. Patientcentric strategies, such as regular mental and physical health assessments, behavioral support, education, and empowerment, are essential in addressing these barriers. Additionally, medicationrelated interventions, including regimen simplification and ensuring affordable access, play a pivotal role in enhancing adherence. Healthcare provider interventions focused on building trust, effective communication, and regular monitoring, combined with healthcare system-level changes such as comprehensive education programs and support services, are critical for fostering an environment conducive to adherence. The review also underscores the significance of a systematic approach, advocating for interdisciplinary collaboration among healthcare professionals and policy-level changes that support adherence-related services and improve resource allocation. Innovative technological solutions, such as MedpeR®, a smart pillbox designed to assist elderly patients, offer practical tools to enhance medication management. The integration of such technologies with traditional approaches can significantly improve adherence rates. Empathy and accessibility in patient-provider relationships are highlighted as crucial factors in promoting adherence, drawing parallels to spiritual teachings that emphasize humility, selflessness, and support. By addressing the diverse barriers to medication adherence through a comprehensive and systematic approach, healthcare providers can improve therapeutic outcomes, reduce healthcare costs, and enhance the quality of life for patients with CVDs. This review provides a foundation for developing targeted interventions and implementing evidence-based strategies to improve medication adherence, particularly among vulnerable elderly populations, thereby contributing to better health outcomes and reduced mortality in CVD management. Keywords: Cardiovascular diseases, Medication adherence, Chronic disease management, Patient-centered care, Technological innovation
INTRODUCTION
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, with a significant impact on public health systems. Managing these chronic conditions requires long-term medication regimens to control risk factors such as hypertension, diabetes, dyslipidemia, and obesity. These regimens are crucial not only for managing existing cardiovascular conditions but also for preventing the onset of new cardiovascular events. Medication adherence, defined by the World Health Organization (WHO) as ‘the degree to which a person's behavior corresponds with the agreed recommendations from a healthcare provider,’ is a fundamental component influencing the effectiveness of these therapeutic regimens [1]. Improving medication adherence in patients with CVDs, particularly in elderly populations, is challenging due to several factors. Elderly patients often suffer from multiple comorbidities, requiring complex polypharmacy regimens that increase the risk of nonadherence. Cognitive decline, age-related sensory impairments, and the high burden of medication costs further complicate adherence. Additionally, socioeconomic factors, such as lack of education about disease management and inadequate healthcare support systems, contribute to poor adherence in these populations. In the context of primary prevention, adherence to medication regimens and lifestyle changes is essential to delay or prevent the progression of CVDs. However, there are significant barriers to adherence, including the asymptomatic nature of early disease stages, the delayed benefits of therapy, the lifelong nature of treatment, and the need for comprehensive lifestyle modifications. To address these challenges, a multifaceted approach that includes both patient-centered and healthcare system-based strategies is necessary. Recent international guidelines for managing hypertension, diabetes, dyslipidemia, and obesity have increasingly focused on adherence issues [2,3]. However, implementing these guidelines in clinical practice remains complex, requiring an integrated, systematic approach that encompasses multiple disciplines. Effective interventions should shift focus from solely patient factors to incorporating the roles of the treatment team and the healthcare system. Strategies such as patient-centered clinical communication, motivational interviewing, decisionmaking through patient empowerment, and a multidisciplinary team approach have been proposed as effective methods to improve adherence. In elderly populations, improving adherence is particularly vital to achieving better therapeutic outcomes and preventing disease progression and complications. The adoption of systematic interventions targeting both patient and system-level barriers can significantly improve adherence rates, leading to reduced morbidity and mortality in this vulnerable group. By focusing on comprehensive care that includes patient education, effective communication strategies, and robust support systems, healthcare providers can foster better adherence behaviors and ultimately enhance patient outcomes in the management of cardiovascular diseases.
Importance of Medication Adherence
Medication adherence is a cornerstone of effective chronic disease management, especially for conditions such as cardiovascular diseases (CVDs). Ensuring that patients consistently follow prescribed medication regimens is critical to achieving therapeutic success. For individuals with cardiovascular conditions, maintaining high levels of adherence can significantly reduce the incidence of adverse cardiovascular events, such as heart attacks and strokes. Improved adherence has been shown to reduce both mortality and the rates of complications, emphasizing its role in primary prevention strategies. Non-adherence to medication regimens, on the other hand, can lead to suboptimal drug levels, reducing the effectiveness of treatments and potentially leading to a progression of the disease. This lack of adherence is associated with increased healthcare utilization, such as more frequent hospitalizations and the need for more intensive medical interventions. Consequently, healthcare costs rise substantially due to the added burden of managing preventable complications and treating exacerbations of chronic conditions. Moreover, non-adherence can exacerbate existing health problems, particularly in patients with multiple co-morbidities. This further diminishes the quality of life and can lead to a decline in functional status, particularly in elderly populations who may already be vulnerable due to age-related factors. Thus, enhancing medication adherence is not only crucial for improving clinical outcomes but also for reducing the overall healthcare costs and improving patients' quality of life by preventing disease progression and complications [4]. Additionally, effective strategies to improve adherence, such as patient education, reminder systems, and tailored interventions, are vital in managing chronic diseases like CVDs. Low-cost interventions, such as those aimed at increasing patient engagement and understanding, have been proven to be cost-effective by reducing the need for more expensive treatments down the line. These strategies highlight the importance of a comprehensive approach to adherence that involves healthcare providers, patients, and the healthcare system, ensuring sustained and effective chronic disease management.
Factors Affecting Medication Adherence
Understanding the factors influencing medication adherence is crucial for developing targeted interventions. These factors can be broadly categorized into patient-related, medication-related, healthcare provider-related, healthcare systemrelated and socioeconomic factors [5].
Patient-Related Factors
Mental State: Depression, cognitive impairment, anxiety, and other mental health issues prevalent in the elderly can impede adherence.
Physical Health: Physical limitations such as poor dexterity or impaired vision can make it difficult for elderly patients to manage their medications.
Demographics: Age, gender, education level, cultural factors, and language barriers can influence adherence behaviors.
Behavior and Attitudes: Habits, attitudes toward medications, use of alternative therapies, and social support networks can affect adherence.
Knowledge and Beliefs: Patients' understanding of their condition and the perceived benefits or burdens of medications are critical to adherence.
Medication-Related Factors
Drug Formulation and Packaging: Complex packaging or formulations that are difficult to handle can deter adherence.
Regimen Complexity: Polypharmacy and frequent changes in medication regimens can overwhelm patients, reducing adherence.
Cost and Side Effects: High medication costs and adverse drug reactions are significant barriers to adherence.
Healthcare Provider-Related Factors
Communication: Effective communication and patient involvement in decision-making foster trust and adherence.
Patient Education: Lack of clear instructions and inadequate patient education on medication importance can hinder adherence.
Healthcare System-Related Factors
Systemic Support: Lack of follow-up, inadequate support services, and poor patient education programs can affect adherence.
Socioeconomic Factors
Caregiver Support: Inadequate caregiver support or high caregiver burden can negatively impact adherence.
Strategies to Improve Medication Adherence
Improving medication adherence in patients with cardiovascular diseases (CVDs) requires a multifaceted approach that considers the various factors influencing adherence, particularly in elderly populations. Strategies must be tailored to address patient-specific, medication-related, healthcare provider, and healthcare system challenges. Effective interventions are crucial to enhance adherence, thereby improving therapeutic outcomes and reducing healthcare costs associated with CVDs [6].
Patient-Centric Interventions
Mental and Physical Health Assessments: Regular assessments are vital to identify cognitive and physical impairments that may hinder a patient's ability to adhere to medication regimens. Cognitive decline, such as memory loss or dementia, can significantly impact a patient’s ability to remember medication schedules. Similarly, physical limitations, including poor dexterity or vision impairment, can make it challenging to handle medication packaging or follow complex dosing instructions. Routine screenings and assessments for cognitive function, mental health conditions (such as depression or anxiety), and physical capabilities should be integrated into the care plan to tailor adherence strategies accordingly.
Behavioral Support and Motivation: Behavioral support is a cornerstone in improving medication adherence. Engaging patients in discussions about their beliefs, attitudes, and understanding of their medications can help address misconceptions and reinforce the benefits of adherence. Motivational interviewing techniques can be employed to explore patients’ ambivalence about taking medications and to enhance their intrinsic motivation. Understanding the patient’s cultural, social, and personal context is essential in developing a personalized adherence plan that resonates with their values and lifestyle.
Education and Empowerment: Patient education is a critical component of adherence strategies. Providing clear, accessible, and comprehensible information about the importance of medication, how it works, and the potential consequences of nonadherence can empower patients to take control of their health. Empowerment strategies should encourage patients to actively participate in decisionmaking processes regarding their treatment plans. Shared decision-making, where patients and healthcare providers collaboratively choose the best therapeutic options, fosters a sense of ownership and commitment to the treatment regimen. Additionally, educational interventions should be continuous and adapted to the patient's evolving needs and health literacy levels.
Medication-Related Interventions
Simplification of Regimens: Simplifying medication regimens is an effective strategy to enhance adherence, especially for elderly patients who are often on multiple medications (polypharmacy). Strategies such as reducing the number of medications, using fixed-dose combination pills (polypills), and aligning medication schedules with daily routines can reduce the complexity of medication regimens. Single-pill combinations are particularly advantageous as they reduce the pill burden, simplify dosing schedules, and minimize the potential for medication errors. Where possible, healthcare providers should aim to prescribe medications with once-daily dosing. Ensuring Affordable Access to Medications: Financial barriers are a significant impediment to medication adherence. Ensuring that medications are affordable, through insurance coverage or costreduction programs, is essential. Strategies such as prescribing generic medications, which are often less expensive than their branded counterparts, and facilitating access to financial assistance programs or subsidies can alleviate the financial burden on patients. Healthcare systems should also advocate for policies that reduce the cost of essential medications and enhance their accessibility to underserved populations.
Healthcare Provider Interventions
Building Trust and Effective Communication: Building a trusting relationship between healthcare providers and patients is fundamental to improving medication adherence. Trust is built through empathetic, transparent, and patient-centered communication. Healthcare providers should employ active listening techniques, provide clear and jargonfree explanations about medication regimens, and ensure that patients feel heard and understood. Encouraging patients to voice their concerns and preferences can foster a collaborative environment where adherence is more likely to be prioritized.
Regular Monitoring and Feedback: Continuous monitoring of medication adherence and providing timely feedback are crucial to sustaining adherence behaviors. Utilizing tools such as electronic health records (EHRs) to track medication refills, selfreporting methods, and digital adherence monitoring devices can help in assessing adherence levels. Regular follow-up appointments to review adherence, discuss any difficulties, and adjust treatment plans as necessary provide opportunities for reinforcing positive behaviors and addressing barriers to adherence. Moreover, engaging patients in selfmonitoring activities, such as maintaining medication diaries or using smartphone apps, can empower them to take an active role in their adherence management.
Healthcare System Interventions
Implementing Comprehensive Patient Education Programs: Healthcare systems should implement robust patient education programs that provide ongoing support and information about medication adherence. These programs should be multifaceted, incorporating various educational formats such as group classes, one-on-one counseling, digital resources, and written materials tailored to different literacy levels. Education should cover not only the technical aspects of medication use but also address behavioral strategies for overcoming common barriers to adherence. Health literacy promotion should be a key focus, as low health literacy has been identified as a significant barrier to effective medication management. Support Services and Community-Based Interventions: Providing support services such as medication management programs, automated reminder systems, and access to community nursing services can significantly enhance adherence rates. Community-based interventions, such as home visits by healthcare professionals, can provide personalized support, monitor medication use, and address any environmental or social barriers to adherence. Additionally, integrating technological solutions, like mobile health apps for medication reminders or telehealth services for remote consultations, can offer scalable and efficient ways to support patients in adhering to their prescribed regimens.
Socioeconomic and Policy Interventions
Addressing Socioeconomic Barriers: Addressing socioeconomic barriers to medication adherence involves a concerted effort from policymakers and healthcare systems to ensure equitable access to healthcare resources. This includes implementing policies that provide financial assistance to lowincome patients, ensuring availability of medications in underserved areas, and developing communitybased support networks that can provide the necessary resources and support for medication management.
Policy Changes and Advocacy: Healthcare systems and policymakers must advocate for changes that prioritize adherence as a public health goal. Policies should focus on incentivizing adherence, such as through value-based insurance design (VBID) that reduces out-of-pocket costs for medications crucial for managing chronic conditions. Additionally, implementing adherence as a quality measure in healthcare delivery can drive systemic improvements and enhance patient outcomes. Improving medication adherence requires a comprehensive, multi-level strategy that incorporates patient-centered care, streamlined medication regimens, robust healthcare provider support, and systemic changes within the healthcare infrastructure. By addressing the diverse barriers to adherence through tailored interventions and coordinated efforts, healthcare providers can significantly improve therapeutic outcomes and quality of life for patients with cardiovascular diseases [5,6].
Innovative Solutions for Medication Adherence: MedpeR®
Technological innovations offer promising solutions to improve medication adherence. MedpeR®, a smart pillbox designed specifically for the elderly, provides a practical example. Developed by Inovocare Healthsoft Solutions Pvt. Ltd., MedpeR® features multiple compartments for different medications, alarm systems for reminders, and assistive refill features to minimize errors. Such devices, which are user-friendly and do not require smartphones for operation, are particularly effective for elderly populations, promoting independence and reducing anxiety around medication management.
Systematic Approaches to Improving Medication Adherence
Improving medication adherence is a complex challenge that requires a comprehensive, systematic approach. The World Health Organization (WHO) emphasizes addressing all elements within the healthcare system to enhance adherence to medication regimens, especially for chronic diseases like cardiovascular conditions. This approach includes several key strategies-
Interdisciplinary Collaboration Interdisciplinary collaboration: It involves fostering teamwork among various healthcare professionals, including doctors, nurses, pharmacists, nutritionists, and behavioral therapists. Each professional brings a unique perspective and set of skills that can contribute to a holistic patient care strategy.
Multidisciplinary Team Approach: Collaboration among healthcare providers can significantly improve patient adherence by ensuring that care is coordinated and that all aspects of the patient's health are considered. For example, nutritionists can provide dietary advice, while pharmacists can assist with medication management. This comprehensive care model helps to address the multifaceted nature of medication adherence, ensuring that patients receive consistent messages and support from all their healthcare providers.
Education and Training: Healthcare providers should receive specialized training on adherence strategies. Training should cover topics such as communication skills, patient empowerment techniques, and motivational interviewing, which are essential for fostering patient engagement and adherence.
Behavioral Interventions
Behavioral interventions: These are central to improving medication adherence and involve strategies tailored to the patient's readiness to change. The transtheoretical model (TTM) is one such framework that stages interventions according to the patient’s readiness for behavioral change.
Transtheoretical Model Application: The TTM posits that patients progress through various stages of change, from pre-contemplation to maintenance. By understanding a patient’s current stage, healthcare providers can tailor their interventions to be more effective. For instance, motivational interviewing techniques can help move a patient from contemplation to action, while relapse prevention strategies can support patients in the maintenance stage.
Information-Motivation-Behavioral Skills Model: This model integrates information dissemination, motivation enhancement, and skill-building to promote adherence. It recognizes that simply providing information is not enough; patients must also be motivated and possess the necessary skills to change their behavior. By employing strategies that increase both motivation and behavioral skills, healthcare providers can more effectively foster behavioral changes that support adherence.
Policy and System-Level Changes
Policy and system-level changes: These are essential to create an environment conducive to adherence. These changes include implementing policies that support adherence-related services, improving healthcare provider education, and allocating resources more effectively. Reimbursement for Adherence-Related Services: Financial incentives can encourage healthcare providers to focus more on adherence-related services. For example, policy changes that reimburse providers for time spent on patient education and follow-up can make it more feasible for them to engage in these activities.
Healthcare System Improvements: Systematic changes, such as the introduction of electronic health records, follow-up systems, and reminder systems, can help track patient adherence and provide timely interventions. Additionally, developing and implementing patient-centered clinical communication (PCCC) strategies can facilitate better patient-provider relationships, which is critical for adherence.
Resource Allocation and Infrastructure Development: Effective adherence programs require adequate resources, such as trained staff and supportive infrastructure. This includes ensuring that healthcare settings are equipped with the necessary tools and technologies to monitor and support patient adherence, such as electronic reminders and remote monitoring systems.
A systematic approach to improving medication adherence involves coordinated efforts across various levels of the healthcare system, including interdisciplinary collaboration, targeted behavioral interventions, and supportive policy changes. These strategies not only enhance the effectiveness of treatment regimens but also improve overall patient outcomes in the management of chronic diseases.
Empathy and Accessibility in Enhancing Medication Adherence
Empathy in the patient-provider relationship is crucial for enhancing medication adherence, much like the spiritual journey described by Shree Krishna in the Bhagavad Gita. In verse 15.5, as shown in figure 1, Shree Krishna explains that to attain the supreme, imperishable abode, one must give up pride and attachments, and cultivate qualities such as humility and selflessness
nirmāna-mohā jita-saṅga-doṣhā adhyātma-nityā vinivṛitta-kāmāḥ| dvandvair vimuktāḥ sukha-duḥkha-sanjñair gachchhanty amūḍhāḥ padam avyayaṁ tat||
Translation: ‘Those who are free from pride and delusion, who have conquered the evil of attachment, who are constantly engaged in the self, who are free from desires, and are beyond the dualities of pleasure and pain, attain that imperishable state.’
Similarly, in healthcare, for patients to achieve better health outcomes through medication adherence, a foundation of empathy and understanding must be established. Just as a soul must overcome pride and ignorance to attain divine knowledge, patients need to overcome psychological barriers-such as fear, mistrust, and a lack of understanding about their medications-to adhere effectively to their treatment regimens. When healthcare providers demonstrate empathy-actively listening, addressing concerns, and providing emotional support-they foster a trusting environment where patients feel valued and understood, thus enhancing adherence to prescribed treatments.
Furthermore, Shree Krishna, in verse 15.6, as shown in figure 2, describes the divine abode, which is selfluminous and not dependent on external sources of light like the sun or moon
na tad bhāsayate sūryo na śhaśhāṅko na pāvakaḥ| yad gatvā na nivartante tad dhāma paramaṁ mama||
Translation: ‘Neither the sun, nor the moon, nor fire can illuminate that Supreme Abode of Mine. Having gone There, one does not return to this material world again.’
This verse underscores the self-sufficiency and perfection of the spiritual realm, created by Yogmaya (spiritual energy), free from the defects and dualities of the material world. Similarly, in healthcare, a systematic and self-sufficient approach is essential to ensuring patients have easy access to their medications, both in terms of availability and affordability. Just as the divine abode is selfilluminating, healthcare systems must be designed to eliminate barriers that prevent patients from obtaining their medications-whether these are financial, logistical, or informational [8,9].
Real-Life Case Scenario
Consider the case of Mrs. TP, a 68-year-old woman with hypertension and type 2 diabetes. Living in a rural area with limited access to healthcare facilities and on a tight budget, Mrs. TP initially struggles with medication adherence due to the high cost of drugs and a lack of understanding about the importance of regular medication intake. Her situation mirrors the spiritual state of ignorance and attachment that Shree Krishna describes, where pride and a lack of knowledge prevent one from surrendering to the divine will. Her healthcare provider, Dr. XYZ, adopts a compassionate and patient-centric approach, much like a spiritual guide leading a soul towards enlightenment. Dr. XYZ spends extra time explaining the significance of each medication, using simple language to ensure Mrs. TP understands, and addresses her concerns empathetically. Recognizing her financial constraints, he finds more affordable medication alternatives and connects her with a community pharmacy that offers discounts for senior citizens. Moreover, understanding the importance of continuous support, Dr. XYZ arranges for a community health worker to visit Mrs. TP regularly. These visits provide ongoing education on medication adherence and emotional support, much like the continuous engagement of a soul in divine service, as described in the scriptures. This consistent, empathetic interaction helps build trust and reinforces the importance of adherence, gradually eliminating Mrs. TP's fears and misconceptions. Over time, Mrs. TP becomes more consistent with her medication regimen, leading to stabilized blood pressure and blood sugar levels, reducing her need for frequent hospital visits. This improvement reflects the analogy of a purified soul attaining the divine abode, free from the cycles of birth and death. Similarly, Mrs. TP's improved adherence frees her from the cycle of frequent medical crises. Empathy and accessibility in healthcare are akin to the spiritual journey towards the divine abode. By addressing both emotional and practical barriers, healthcare providers can help patients like Mrs. TP achieve better health outcomes, mirroring the soul's journey towards enlightenment and eternal bliss, as described in the Bhagavad Gita.
CONCLUSION
Medication adherence is a cornerstone in the management and prevention of cardiovascular diseases, particularly among the elderly. A comprehensive understanding of the factors influencing adherence and the implementation of targeted, systematic strategies are essential for improving adherence rates. Technological innovations like MedpeR® and systematic approaches involving interdisciplinary collaboration, policy changes, and patient-centered care models offer promising avenues to enhance adherence. By improving adherence, healthcare providers can achieve better therapeutic outcomes, reduce healthcare costs, and improve the overall quality of life for patients with cardiovascular diseases.
REFERENCES
1. World Health Organization. (2003). Adherence to long-term therapies: evidence for action. World Health Organization.
2. Wander, G. S., Panda, J. K., Pal, J., Mathur, G., Sahay, R., Tiwaskar, M., Chatterjee, N., Chakrabarty, S., Singh, D. P., Murthy, L. S., Ghosh, S., Samajdar, S. S., & Maheswari, S. (2024). Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians. The Journal of the Association of Physicians of India, 72(8), e1–e25. https://doi.org/10.59556/japi.72.0620
3. American Diabetes Association Professional Practice Committee (2024). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes care, 47(Suppl1), S158–S178. https://doi.org/10.2337/dc24-S009
4. Valgimigli, M., Garcia-Garcia, H. M., Vrijens, B., Vranckx, P., McFadden, E. P., Costa, F., Pieper, K., Vock, D. M., Zhang, M., Van Es, G. A., Tricoci, P., Baber, U., Steg, G., Montalescot, G., Angiolillo, D. J., Serruys, P. W., Farb, A., Windecker, S., Kastrati, A., Colombo, A., … Tijssen, J. G. P. (2019). Standardized classification and framework for reporting, interpreting, and analysing medication nonadherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). European heart journal, 40(25), 2070–2085. https://doi.org/10.1093/eurheartj/ehy377
5. Ihm, S. H., Kim, K. I., Lee, K. J., Won, J. W., Na, J. O., Rha, S. W., Kim, H. L., Kim, S. H., & Shin, J. (2022). Interventions for Adherence Improvement in the Primary Prevention of Cardiovascular Diseases: Expert Consensus Statement. Korean circulation journal, 52(1), 1–33. https://doi.org/10.4070/kcj.2021.0226
6. Ogungbe, O., Byiringiro, S., AdedokunAfolayan, A., Seal, S. M., Dennison Himmelfarb, C. R., Davidson, P. M., & Commodore-Mensah, Y. (2021). Medication Adherence Interventions for Cardiovascular Disease in Low- and Middle-Income Countries: A Systematic Review. Patient preference and adherence, 15, 885–897. https://doi.org/10.2147/PPA.S296280
7. Xu, H. Y., Yu, Y. J., Zhang, Q. H., Hu, H. Y., & Li, M. (2020). Tailored Interventions to Improve Medication Adherence for Cardiovascular Diseases. Frontiers in pharmacology, 11, 510339.https://doi.org/10.3389/fphar.2020. 510339
8. Samajdar, S. S., Joshi, S. R., Tripathi, R., Mukherjee, S., Pal, J., Moitra, S., & Tripathi, S.K. (2024). Spiritual lessons from Shrimad Bhagavad Gita for healthcare providers: A few COVID-19 cases. J Mod Med, 2(1), 38-41. https://doi:10.4103/JOMM.JOMM_7_23.
9. Mukundananda, S. (n.d.). Bhagavad Gita - The Song of God. Retrieved September 1, 2024, from https://www.holy-bhagavad-gita.org/
Comentários